-
公开(公告)号：US20090227566A1
公开(公告)日：2009-09-10
申请号：US11719415
申请日：2005-11-10
申请人： Ankush Baburao Argade , Theodore Goodson, JR. , David Kent Herron , Sajan Joseph , Salvatore Donato Lepore , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Anne Lousie Tebbe , Michael Robert Wiley , Ying Kwong Yee
发明人： Ankush Baburao Argade , Theodore Goodson, JR. , David Kent Herron , Sajan Joseph , Salvatore Donato Lepore , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Anne Lousie Tebbe , Michael Robert Wiley , Ying Kwong Yee
IPC分类号： A61K31/551 , A61K31/5377 , A61K31/445 , C07D243/08 , C07D413/12 , C07D401/12 , C07D211/98
CPC分类号： C07D211/46 , C07C229/38 , C07D213/75 , C07D295/192 , C07D333/38 , C07D401/12 , C07D401/14 , C07D409/06 , C07D409/14 , C07D413/12 , C07D417/12
摘要： This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor. An example of a compound of formula (I) is (a).
摘要翻译： 本申请涉及如本文所定义的式（I）化合物（或其化合物或前药的药学上可接受的盐），其药物组合物及其作为因子Xa和/或凝血酶抑制剂的用途，以及 其制备方法及其中间体。 式（I）化合物的实例是（a）。
-
公开(公告)号：US07700628B2
公开(公告)日：2010-04-20
申请号：US11719415
申请日：2005-11-10
申请人： Ankush Baburao Argade , Theodore Goodson, Jr. , David Kent Herron , Sajan Joseph , Salvatore Donato Lepore , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Anne Louise Tebbe , Michael Robert Wiley , Ying Kwong Yee
发明人： Ankush Baburao Argade , Theodore Goodson, Jr. , David Kent Herron , Sajan Joseph , Salvatore Donato Lepore , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Anne Louise Tebbe , Michael Robert Wiley , Ying Kwong Yee
IPC分类号： C07D413/10 , C07D413/14 , C07D401/10 , C07D401/02 , C07D401/14 , C07D401/12 , C07D409/10 , C07D243/08 , C07D213/75 , A61K31/381 , A61K31/4402 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/5377 , A61K31/551
CPC分类号： C07D211/46 , C07C229/38 , C07D213/75 , C07D295/192 , C07D333/38 , C07D401/12 , C07D401/14 , C07D409/06 , C07D409/14 , C07D413/12 , C07D417/12
摘要： This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor. An example of a compound of formula (I) is (a).
摘要翻译： 本申请涉及如本文所定义的式（I）化合物（或其化合物或前药的药学上可接受的盐），其药物组合物及其作为因子Xa和/或凝血酶抑制剂的用途，以及 其制备方法及其中间体。 式（I）化合物的实例是（a）。
-
公开(公告)号：US07511066B2
公开(公告)日：2009-03-31
申请号：US10571373
申请日：2004-09-24
申请人： Jeffry Bernard Franciskovich , Theodore Goodson, Jr. , David Kent Herron , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Michael Robert Wiley , Ying Kwong Yee
发明人： Jeffry Bernard Franciskovich , Theodore Goodson, Jr. , David Kent Herron , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Michael Robert Wiley , Ying Kwong Yee
IPC分类号： A61K31/4427 , C07D417/12
CPC分类号： C07C49/84 , C04B35/632 , C07C65/05 , C07C65/21 , C07D213/81 , C07D295/155 , C07D317/30 , C07D401/12 , C07D401/14 , C07D405/14 , C07D409/12 , C07D409/14 , C07D417/14
摘要： This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor.
摘要翻译： 本申请涉及如本文所定义的式I化合物（或其前体药物或其药学上可接受的盐），其药物组合物及其作为因子Xa和/或凝血酶抑制剂的用途，以及 作为其制备方法及其中间体。
-
公开(公告)号：US07615568B2
公开(公告)日：2009-11-10
申请号：US10556313
申请日：2004-04-13
申请人： Jeffry Bernard Franciskovich , David Kent Herron , Jared Harris Linebarger , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Leland Otto Weigel , Michael Robert Wiley , Ying Kwong Yee
发明人： Jeffry Bernard Franciskovich , David Kent Herron , Jared Harris Linebarger , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Leland Otto Weigel , Michael Robert Wiley , Ying Kwong Yee
IPC分类号： A61K31/4427 , C07D417/12
CPC分类号： C07D213/79 , C07C317/46 , C07C323/62 , C07C2601/14 , C07D207/12 , C07D211/46 , C07D213/81 , C07D401/14
摘要： This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor (I).
摘要翻译： 本申请涉及如本文所定义的式I化合物（或其前体药物或其药学上可接受的盐），其药物组合物及其作为因子Xa和/或凝血酶抑制剂的用途，以及 作为其制备方法及其中间体（I）。
-
公开(公告)号：US20080108594A1
公开(公告)日：2008-05-08
申请号：US10556313
申请日：2004-04-13
申请人： Jeffry Bernard Franciskovich , David Kent Herron , Jared Harris Linebarger , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Leland Otto Weigel , Michael Robert Wiley , Ying Kwong Yee
发明人： Jeffry Bernard Franciskovich , David Kent Herron , Jared Harris Linebarger , Angela Lynn Marquart , John Joseph Masters , David Mendel , Leander Merritt , Andrew Michael Ratz , Gerald Floyd Smith , Leland Otto Weigel , Michael Robert Wiley , Ying Kwong Yee
IPC分类号： C07D401/02 , A61K31/397 , A61K31/4545 , A61K31/444 , A61P7/02
CPC分类号： C07D213/79 , C07C317/46 , C07C323/62 , C07C2601/14 , C07D207/12 , C07D211/46 , C07D213/81 , C07D401/14
摘要： This application relates to a compound of formula I (or a pro-drug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor (I).
摘要翻译： 本申请涉及如本文所定义的式I化合物（或其前体药物或其药学上可接受的盐），其药物组合物及其作为因子Xa和/或凝血酶抑制剂的用途， 以及其制备方法及其中间体（I）。
-
公开(公告)号：US07666866B2
公开(公告)日：2010-02-23
申请号：US11719972
申请日：2005-11-15
申请人： Jeffry Bernard Franciskovich , David Kent Herron , Valentine Joseph Klimkowski , Angela Lynn Marquart , John Joseph Masters , David Mendel , Andrew Michael Ratz , Gerald Floyd Smith , Michael Robert Wiley , Ying Kwong Yee
发明人： Jeffry Bernard Franciskovich , David Kent Herron , Valentine Joseph Klimkowski , Angela Lynn Marquart , John Joseph Masters , David Mendel , Andrew Michael Ratz , Gerald Floyd Smith , Michael Robert Wiley , Ying Kwong Yee
IPC分类号： A61K31/535 , A61K31/445 , A61K31/44 , A61K31/425 , A61K31/42 , A61K31/41 , A61K31/415 , A61K31/40 , A61K31/38 , A61K31/34 , C07D265/30 , C07D211/44 , C07D213/00 , C07D277/00 , C07D261/18 , C07D257/04 , C07D231/00 , C07D207/00 , C07D333/22 , C07D333/00 , C07D307/02
CPC分类号： C07D213/75 , C07C235/64 , C07C237/06 , C07C271/16 , C07C275/10 , C07C275/16 , C07C275/26 , C07C275/28 , C07C275/30 , C07D211/22 , C07D211/46 , C07D295/088 , C07D295/192 , C07D295/205 , C07D295/215 , C07D401/12 , C07D409/12 , C07D409/14
摘要： This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt of the compound) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor.
摘要翻译： 本申请涉及如本文所定义的式（I）化合物（或其化合物的药学上可接受的盐），其药物组合物及其作为因子Xa和/或凝血酶抑制剂的用途，以及其用于 制剂及其中间体。
-
公开(公告)号：US20090062271A1
公开(公告)日：2009-03-05
申请号：US11719972
申请日：2005-11-15
申请人： Jeffry Bernard Franciskovich , David Kent Herron , Valentine Joseph Klimkowski , Angela Lynn Marquart , John Joseph Masters , David Mendel , Andrew Michael Ratz , Gerald Floyd Smith , Michael Robert Wiley , Ying Kwong Yee
发明人： Jeffry Bernard Franciskovich , David Kent Herron , Valentine Joseph Klimkowski , Angela Lynn Marquart , John Joseph Masters , David Mendel , Andrew Michael Ratz , Gerald Floyd Smith , Michael Robert Wiley , Ying Kwong Yee
IPC分类号： A61K31/4545 , C07D211/06 , A61K31/5375 , A61P7/02 , C07D265/30
CPC分类号： C07D213/75 , C07C235/64 , C07C237/06 , C07C271/16 , C07C275/10 , C07C275/16 , C07C275/26 , C07C275/28 , C07C275/30 , C07D211/22 , C07D211/46 , C07D295/088 , C07D295/192 , C07D295/205 , C07D295/215 , C07D401/12 , C07D409/12 , C07D409/14
摘要： This application relates to a compound of formula I (or a pharmaceutically acceptable salt of the compound) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor.
摘要翻译： 本申请涉及如本文所定义的式I化合物（或其化合物的药学上可接受的盐），其药物组合物及其作为因子Xa和/或凝血酶抑制剂的用途，以及其制备方法和 中间体。
-
公开(公告)号：US07163938B2
公开(公告)日：2007-01-16
申请号：US10415756
申请日：2001-11-14
申请人： David Kent Herron , Sajan Joseph , Angela Lynn Marquart , John Joseph Masters , David Mendel , Gerald Floyd Smith , Philip Parker Waid , Michael Robert Wiley , Ying Kwong Yee
发明人： David Kent Herron , Sajan Joseph , Angela Lynn Marquart , John Joseph Masters , David Mendel , Gerald Floyd Smith , Philip Parker Waid , Michael Robert Wiley , Ying Kwong Yee
IPC分类号： A61P7/00 , A61K31/44 , A61K31/55 , C07D213/00 , C07D401/12
CPC分类号： C07D213/75 , C07D213/81 , C07D401/12 , C07D401/14
摘要： This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
摘要翻译： 本申请涉及如本文所定义的式I化合物（或其药学上可接受的盐），其药物组合物及其作为因子Xa抑制剂的用途，以及其制备方法及其中间体。
-
公开(公告)号：US07160878B2
公开(公告)日：2007-01-09
申请号：US10332120
申请日：2001-07-18
申请人： David Kent Herron , Sajan Joseph , Angela Lynn Marquart , John Joseph Masters , David Mendel , Gerald Floyd Smith , Philip Parker Waid , Michael Robert Wiley , Ying Kwong Yee
发明人： David Kent Herron , Sajan Joseph , Angela Lynn Marquart , John Joseph Masters , David Mendel , Gerald Floyd Smith , Philip Parker Waid , Michael Robert Wiley , Ying Kwong Yee
IPC分类号： A61P7/02 , A61K31/55 , C07D243/08
CPC分类号： C07D401/14 , C07D237/24 , C07D403/04
摘要： This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
摘要翻译： 本申请涉及本文所定义的式（I）化合物（或其药学上可接受的盐），其药物组合物及其作为因子Xa抑制剂的用途，以及其制备方法及其中间体。
-
公开(公告)号：US07449457B2
公开(公告)日：2008-11-11
申请号：US10497250
申请日：2002-12-02
申请人： David Kent Herron , Sajan Joseph , Angela Lynn Marquart , John Joseph Masters , David Mendel , Gerald Floyd Smith , Anne Louise Tebbe , Philip Parker Waid , Michael Robert Wiley , Ying Kwong Yee
发明人： David Kent Herron , Sajan Joseph , Angela Lynn Marquart , John Joseph Masters , David Mendel , Gerald Floyd Smith , Anne Louise Tebbe , Philip Parker Waid , Michael Robert Wiley , Ying Kwong Yee
IPC分类号： A61K31/54 , A61K31/44 , A61K31/535 , C07D417/00 , C07D413/00 , C07D401/00
CPC分类号： C07D213/81 , C07D213/82 , C07D401/12 , C07D401/14 , C07D453/02
摘要： This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
摘要翻译： 本申请涉及本文所定义的式（I）化合物（或其药学上可接受的盐），其药物组合物及其作为因子Xa抑制剂的用途，以及其制备方法及其中间体。
-
-
-
-
-
-
-
-
-
搜索结果
45 条记录 (耗时 0.077 秒)
